Welcome to CureVac fourth-quarter and full year 2024 financial results and business update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

Protalix BioTherapeutics is profitable with key pipeline momentum and strategic interest. Check out why PLX stock is a strong ...

RBC Capital lowered the firm’s price target on Gen Digital (GEN) to $28 from $30 and keeps a Sector Perform rating on the shares as part of a ...